Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_assertion type Assertion NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_head.
- NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_assertion description "[It is not well defined whether the addition of anti-VEGF and anti-EGFR to chemotherapy could improve outcome in those patients susceptible to CRC-related metastases resection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_provenance.
- NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_assertion evidence source_evidence_literature NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_provenance.
- NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_assertion SIO_000772 23441760 NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_provenance.
- NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_assertion wasDerivedFrom befree-20140225 NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_provenance.
- NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_assertion wasGeneratedBy ECO_0000203 NP166151.RAT4OLvX53NmrleWF64V-kcGWDUDEVVR3_y-lebaXp4Xc130_provenance.